Keyphrases
Pregnancy Outcome
100%
Antiphospholipid Syndrome
100%
Progressive multiple Sclerosis
100%
Pregnancy Loss
83%
Multicenter Cohort
83%
Clinical Manifestations
80%
Miscarriage
66%
Stillbirth
66%
Maternal Pregnancy
58%
Preeclampsia
58%
Antiphospholipid Antibodies
57%
European League against Rheumatism (EULAR)
57%
Live Birth Rate
56%
Multiple Sclerosis
56%
Vaccine Safety
55%
During Pregnancy
50%
COVID-19 Vaccination
50%
Alemtuzumab
50%
Mixed Connective Tissue Disease
50%
Aspirin
50%
Autoimmune Inflammatory Rheumatic Disease
50%
Heparin
50%
Coronavirus Disease 2019 Vaccine
50%
Fetomaternal Outcome
50%
Anti-phosphatidylserine/prothrombin
50%
Antiprothrombin Antibodies
50%
Autoimmune Disease
50%
Denmark
50%
Microstructural
50%
Adult Patients
50%
Disease Evolution
50%
Neurofilament Light (NF-L)
50%
Cognitive Function
50%
Small nuclear Ribonucleoprotein (snRNP)
50%
Connective Tissue Dysplasia
50%
Quality of Life
50%
Brain Injury
50%
Vaccination
50%
Glial Fibrillary Acidic Protein
50%
Fetal Diseases
50%
Cognitive Qualities
50%
Live Birth
46%
Odds Ratio
41%
Selective Intrauterine Growth Restriction (sIUGR)
41%
Gestational Diabetes
41%
Gestational Hypertension
41%
Multicenter Retrospective Cohort Study
41%
Healthy Controls
38%
Fetal Outcome
33%
Adverse Events
31%
Medicine and Dentistry
Antiphospholipid Syndrome
100%
Pregnancy
66%
Spontaneous Abortion
58%
Stillbirth
58%
Antiphospholipid Antibody
57%
Disease Course
50%
Rheumatic Disease
50%
Mixed Connective Tissue Disease
50%
Heparin
50%
Acetylsalicylic Acid
50%
Connective Tissue Disease
50%
Prothrombin Antibody
50%
Prothrombin
50%
Birth Rate
48%
Childbirth
38%
Odds Ratio
35%
Intrauterine Growth Retardation
33%
Gestational Hypertension
33%
Gestational Diabetes
33%
Retrospective Cohort Study
33%
Pre-Eclampsia
33%
Pregnancy Complication
30%
Photosensitivity
25%
High Risk Population
25%
Immunoglobulin M
21%
Low Risk Population
15%
Systematic Review
11%
Disease
11%
Congenital Heart Block
8%
Heart Block
8%
Ro Antibody
8%
Household
8%
Live Vaccine
8%
First Trimester Pregnancy
8%
Eclampsia
8%
Lupus Erythematosus
8%
Patient Population
7%
Thrombosis
7%
Low Drug Dose
5%
Low Molecular Weight Heparin
5%
